Episode summary

Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In Focus | Stock Market Today

Stock Market Today With Ibd · · Hosts: Alissa Coram, Ken Shreve

Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In Focus | Stock Market Today – Stock Market Today With Ibd

Summary

The Nasdaq eked out a 0.4% gain and posted the first day of a rally attempt, but the broader tape stayed mixed: the Dow fell 1.1%, the S&P 500 slipped about 0.25%, and both remain under pressure near their 200-day lines. The discussion framed the session as a narrow win for bulls, with strength in retail and cyber security offset by weakness in much of technology and healthcare.

Nvidia’s earnings were described as strong on revenue, earnings, and guidance, but the stock still fell almost 3% after the report amid lingering uncertainty, including an SEC investigation and questions around leadership. The hosts also said a wave of selling hit health insurers after government steps to curb insurance fraud, dragging down UnitedHealth and the Dow. Oil and Treasury yields moved lower as well, while Fed commentary kept December rate expectations in focus.

On the stock watchlist, Target stood out with a breakout attempt after a solid quarter, Rhythm Pharmaceuticals drew interest as a revenue biotech with strong fund sponsorship, and Affiliated Managers Group moved back into a buy zone with improving relative strength. Cybersecurity names also showed unusual strength ahead of Palo Alto Networks’ earnings.

Key takeaways

  • The hosts said the Nasdaq’s 0.4% gain was enough to mark day one of a rally attempt, even as the Dow and S&P 500 remained weak.
  • Nvidia’s quarter was described as excellent, but the stock still fell almost 3% because of broader uncertainty and an SEC investigation.
  • Health insurers were hit again after government fraud-curb actions, with UnitedHealth and the Dow under the most pressure.
  • Cybersecurity stocks outperformed sharply, with the BUG ETF up almost 8% ahead of Palo Alto Networks earnings.
  • Target’s breakout attempt was supported by 49% earnings growth and 7% sales growth, but sellers pushed it off highs by the close.
  • Rhythm Pharmaceuticals and AMG were highlighted for strong technical action and institutional interest.

Notable quotes

“we did get a first day of a rally attempt for the NASDAQ composite today”

— A speaker on Stock Market Today With Ibd at 1:53

“Target, we'll take a look at Target. Also, a biotech rhythm pharmaceuticals”

— A speaker on Stock Market Today With Ibd at 0:44

“it was a pretty good quarter here. Earnings growth up 49%. Singledigit topline growth”

— A speaker on Stock Market Today With Ibd at 20:58

Topics

  • nvidia earnings
  • nasdaq market action
  • stock picks
  • retail stocks
  • biotech stocks

Companies and tickers mentioned

  • NVDA
  • TGT
  • RYTM
  • AMG
  • Nvidia
  • Target
  • Rhythm Pharma
  • AMG

Watch the episode

Watch “Nasdaq Ekes Out Gain After Nvidia Earnings; Target, Rhythm Pharma, AMG In Focus | Stock Market Today” on YouTube

Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.

More from Stock Market Today With Ibd

All Stock Market Today With Ibd episodes →

Stock Market Today With Ibd, this episode and its artwork belong to their owners. Octagon is not affiliated with the show; this page is an independent summary.